Publications by authors named "Barbara Grun"

Claim this Profile
A
Activity and Safety of Avelumab in High-Grade Neuroendocrine Tumors and Poorly Differentiated Neuroendocrine Carcinomas Progressive after Chemotherapy (AveNEC Trial).
Christian Fottner, Leonidas Apostolidis, Sebastian Krug, Anja Rinke, Barbara Grün

Clin Cancer Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma-a phase II trial of the AIO study group (AIO STO 0321).
Joseph Tintelnot, Alexander Stein, Salah-Eddin Al-Batran, Thomas Ettrich, Thorsten Götze

Front Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer - The PICCASSO phase I trial.
Georg Martin Haag, Christoph Springfeld, Barbara Grün, Leonidas Apostolidis, Stefanie Zschäbitz

Eur J Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interprofessional evidence-based counselling programme for complementary and integrative healthcare in patients with cancer: study protocol for the controlled implementation study CCC-Integrativ.
Jan Valentini, Daniela Fröhlich, Regina Stolz, Cornelia Mahler, Peter Martus

BMJ Open· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Checkpoint Inhibitor Treatment in Patients with Advanced Renal or Urothelial Cell Carcinoma and Concomitant Chronic Kidney Disease: A Retrospective Cohort Study.
Florian Seydel, Susanne Delecluse, Martin Zeier, Tim Holland-Letz, Georg Martin Haag

Cancers (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Completion rate and impact on physician-patient relationship of video consultations in medical oncology: a randomised controlled open-label trial.
Thomas Walle, Erkin Erdal, Leon Mühlsteffen, Hans Martin Singh, Editha Gnutzmann

ESMO Open· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NPPB is a novel candidate biomarker expressed by cancer-associated fibroblasts in epithelial ovarian cancer.
Kate Lawrenson, Barbara Grun, Nathan Lee, Paulette Mhawech-Fauceglia, Jenny Kan

Int J Cancer· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trimethoprim-metformin interaction and its genetic modulation by OCT2 and MATE1 transporters.
Barbara Grün, Michael K Kiessling, Jürgen Burhenne, Klaus-Dieter Riedel, Johanna Weiss

Br J Clin Pharmacol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of CYP2C19 and CYP3A4 to the formation of the active nortilidine from the prodrug tilidine.
Barbara Grün, Ulrike Merkel, Klaus-Dieter Riedel, Johanna Weiss, Gerd Mikus

Br J Clin Pharmacol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterotypic three-dimensional in vitro modeling of stromal-epithelial interactions during ovarian cancer initiation and progression.
Kate Lawrenson, Barbara Grun, Simon A Gayther

J Vis Exp· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling genetic and clinical heterogeneity in epithelial ovarian cancers.
Kate Lawrenson, Duncan Sproul, Barbara Grun, Maria Notaridou, Elizabeth Benjamin

Carcinogenesis· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers.
Dimitra Dafou, Barbara Grun, John Sinclair, Kate Lawrenson, Elizabeth C Benjamin

Neoplasia· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Senescent fibroblasts promote neoplastic transformation of partially transformed ovarian epithelial cells in a three-dimensional model of early stage ovarian cancer.
Kate Lawrenson, Barbara Grun, Elizabeth Benjamin, Ian J Jacobs, Dimitra Dafou

Neoplasia· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of the active principle of the weak opioid tilidine by the triazole antifungal voriconazole.
Barbara Grün, Stefanie Krautter, Klaus-Dieter Riedel, Gerd Mikus

Br J Clin Pharmacol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromosomes 6 and 18 induce neoplastic suppression in epithelial ovarian cancer cells.
Dimitra Dafou, Susan J Ramus, Ken Choi, Barbara Grun, Deborah A Trott

Int J Cancer· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Antihypertensive pharmacotherapy of patients in primary care with either a statutory or private health insurance].
Gunter Laux, Joachim Szecsenyi, Antje Miksch, Barbara Grün, Andreas Gutscher

Med Klin (Munich)· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
ROC analysis comparison of three assays for the detection of antibodies against double-stranded DNA in serum for the diagnosis of systemic lupus erythematosus.
Jan-Christian Wasmuth, Barbara Grün, Birgit Terjung, Angela Homrighausen, Ulrich Spengler

Clin Chem· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis